Search results for: NHS Expenditure
Filter search results
NICE ‘Optimised’ Recommendations: What Do They Mean for Patient Access?
30 July 2020
…Health Service (NHS) in England based on their clinical and cost-effectiveness, through their Technology Appraisal (TA) programme. Following review, the main TA outcomes are to ‘recommend’ the medicine (in line…
Are Discount Rates Used in UK Vaccine Economic Evaluations Jeopardising Investment in Immunisation Programmes?
4 August 2020
…loss in informal care, in addition to the medical costs falling on the NHS. Using a model-based approach, using published literature to inform model input parameters, we estimated the lifetime…
Establishing a Reasonable Price for an Orphan Drug
11 September 2020
…assessment with risk aversion in health. Journal of Health Economics: https://doi.org/10.1016/j.jhealeco.2020.102346 McCabe, C., Claxton, K. and Tsuchiya, A., 2005. Orphan drugs and the NHS: should we value rarity? Bmj, 331(7523),…
The Value of Diagnostic information (VODI) in Heart Failure – Recognising Value Beyond ‘Beats-Per-Minute’
3 December 2020
…The Netherlands, and by Ms Carys Barton, Heart Failure Nurse Consultant at Imperial College Healthcare NHS Trust and Chair of the British Society for Heart Failure Nurse Forum. Both stressed…
Patient Participation Awareness Week 2022
30 May 2022
…(NHS) and other health systems. This includes decisions about their own care but also decisions that can affect how and which services are provided to other patients or the wider…
OHE’s 60th Anniversary Party – Celebrating Our Achievements and Looking Forward
21 June 2022
…Adrian also referred to the sadly not-so-successful (yet) campaign for the routine collection of the Patient-Reported Outcome Measure set in the NHS. Adrian thanked John Sussex, former Deputy Director of…
Health and the Use of Medicines in Primary Care in Wales
1 November 2011
…that overall NHS spending in Wales has been growing faster than spending on medicines. Other recent research, referenced in the report, has suggested that Health Boards in Wales consistently underspend…
The challenges and economics of drug development in 2022
1 July 2013
…medical sciences for generations. Recommendations from the conference for ensuring this continues include making full use of the unique resources of the NHS and creating vigorous clusters of research excellence….
Critique of CHE Research Paper 81: Methods for the Estimation of the NICE Cost Effectiveness Threshold
12 January 2013
…the NHS to produce one less QALY. However, it argues that the £12,936 estimate has two serious difficulties: (1) important data are unavailable and therefore assumptions have to be made…